Evidence map›Paper›PMID 27974664›Full record

Observational studyScience translational medicine2016

Aggregatibacter actinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis.

Maximilian F Konig, Loreto Abusleme, Jesper Reinholdt, Robert J Palmer, Ricardo P Teles, Kevon Sampson, Antony Rosen, Peter A Nigrovic, Jeremy Sokolove, Jon T Giles and 2 more

Registry-linked trialOpen access · greenAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Science translational medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06450821 (PROSpECT-PRIOR-2-CHEMO), which is not on this map. Cited by 346 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
346citing papers in PubMed, 6 pooled it
45.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06450821 nanot yet recruitingnot on this mapstarted 2024, after this paper: background citation

PROSpECT-PRIOR-2-CHEMO: A Feasibility RCT of Novel Dental Intervention PRIOR[Proactive Intensive Oral Review & Treatment] in Patients Scheduled for Chemotherapy for Myeloma-ASCT & Hematological Cancers to Mitigate Chemotherapy Complications

TypeinterventionalSponsorUniversity of LeedsRan2024 to 2026Enrolled60ConditionsOncology, Periodontitis, Myeloma, Oral MucositisArmsPRIOR [Proactive Intensive Oral Review & Treatment]
3 · Its place in the literature

Who cites it

346 citing papers in PubMed, 6 syntheses or guidelines pooled it, 539 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Cross-presentation of citrullinated antigens drives cytotoxic CD8bioRxiv : the preprint server for biology · 2026
    Article
  19. Review
  20. hLife · 2026
    Review

286 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 2 countries.

Maximilian F KonigDivision of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA.
Loreto AbuslemeNational Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892, USA.
Jesper ReinholdtDepartment of Biomedicine, Aarhus University, 8000 Aarhus C, Denmark.
Robert J PalmerNational Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892, USA.
Ricardo P TelesDepartment of Periodontology, School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Kevon SampsonDivision of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA.
Antony RosenDivision of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA.
Peter A NigrovicDivision of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA 02115, USA.
Jeremy SokoloveDivision of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Jon T GilesDivision of Rheumatology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.
Niki M MoutsopoulosNational Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892, USA.
Felipe AndradeDivision of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA. andrade@jhmi.edu.
Johns Hopkins University · USNational Institute of Dental and Craniofacial Research · USAarhus University · DKBrigham and Women's Hospital · USJohns Hopkins Medicine · USNational Institutes of Health · USStanford University · US

Funding

Biomarkers of Periodontal Disease ProgressionU01DE021127 · NIDCR · ADA FORSYTH INSTITUTE, INC. · PI TELES, RICARDO P · 2010 to 2016
$16.2M
Mechanisms of Chronic Inflammation in PeriodontitisZIADE000736 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI MOUTSOPOULOS, NIKI · 2010 to 2025
$14.1M
Inflammation and Cardiovascular Disease in Rheumatoid ArthritisR01AR050026 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI BATHON, JOAN MARIE · 2004 to 2022
$9.7M
Apoptosis in Sjogrens SyndromeR37DE012354 · NIDCR · JOHNS HOPKINS UNIVERSITY · PI ROSEN, ANTONY · 2002 to 2011
$5.3M
Ly6 family members in neutrophil biologyR01AR065538 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI NIGROVIC, PETER A · 2014 to 2024
$4.0M
Mechanisms in Sjogrens SyndromeR01DE012354 · NIDCR · JOHNS HOPKINS UNIVERSITY · PI ROSEN, ANTONY · 1998 to 2017
$3.4M
The role of complement citrullination in RA pathogenesisR01AR069569 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI ANDRADE, FELIPE · 2016 to 2020
$1.8M
Inflammation and Cardiovascular Disease in RAR55AR050026 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI BATHON, JOAN MARIE · 2003 to 2003
$100k
NIAMS NIH HHS R01 AR050026NIAMS NIH HHS R01 AR065538NIAMS NIH HHS R01 AR069569NIAMS NIH HHS R55 AR050026NIDCR NIH HHS R01 DE012354NIDCR NIH HHS R37 DE012354NIDCR NIH HHS U01 DE021127
6 · The paper itself

Abstract

A bacterial etiology of rheumatoid arthritis (RA) has been suspected since the beginnings of modern germ theory. Recent studies implicate mucosal surfaces as sites of disease initiation. The common occurrence of periodontal dysbiosis in RA suggests that oral pathogens may trigger the production of disease-specific autoantibodies and arthritis in susceptible individuals. We used mass spectrometry to define the microbial composition and antigenic repertoire of gingival crevicular fluid in patients with periodontal disease and healthy controls. Periodontitis was characterized by the presence of citrullinated autoantigens that are primary immune targets in RA. The citrullinome in periodontitis mirrored patterns of hypercitrullination observed in the rheumatoid joint, implicating this mucosal site in RA pathogenesis. Proteomic signatures of several microbial species were detected in hypercitrullinated periodontitis samples. Among these, Aggregatibacter actinomycetemcomitans (Aa), but not other candidate pathogens, induced hypercitrullination in host neutrophils. We identified the pore-forming toxin leukotoxin A (LtxA) as the molecular mechanism by which Aa triggers dysregulated activation of citrullinating enzymes in neutrophils, mimicking membranolytic pathways that sustain autoantigen citrullination in the RA joint. Moreover, LtxA induced changes in neutrophil morphology mimicking extracellular trap formation, thereby releasing the hypercitrullinated cargo. Exposure to leukotoxic Aa strains was confirmed in patients with RA and was associated with both anticitrullinated protein antibodies and rheumatoid factor. The effect of human lymphocyte antigen-DRB1 shared epitope alleles on autoantibody positivity was limited to RA patients who were exposed to Aa These studies identify the periodontal pathogen Aa as a candidate bacterial trigger of autoimmunity in RA.

Indexed as

Aggregatibacter actinomycetemcomitansAdultAnti-Citrullinated Protein AntibodiesArthritis, RheumatoidAutoantigensCase-Control StudiesChronic DiseaseCitrullineClinical Trials as TopicFemaleHLA-DRB1 ChainsHumansMaleMiddle AgedNeutrophilsPasteurellaceae InfectionsAnti-Citrullinated Protein AntibodiesAutoantigensCitrullineHLA-DRB1 Chains

Identifiers

PMID27974664
PMCPMC5384717
OpenAlexW2562800512

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.